What is the significance of the total number of sequences in a “Sequence Listing XML”?
The total number of sequences in a “Sequence Listing XML” is a crucial aspect of the document’s completeness and accuracy. According to MPEP 2412.05(a): “The total number of sequences must be indicated in the ‘Sequence Listing XML’ and must equal the total number of sequence identifiers, whether followed by a sequence or by ‘000’.” This…
Read MoreWhat are the requirements for sequence identifiers in a “Sequence Listing XML”?
According to MPEP 2412.05(a), sequence identifiers in a “Sequence Listing XML” must adhere to specific requirements: Each disclosed nucleotide or amino acid sequence meeting the requirements of 37 CFR 1.831(b) must appear separately in the “Sequence Listing XML”. Each sequence must be assigned a separate sequence identifier. Sequence identifiers must begin with 1 and increase…
Read MoreWhat is considered a “sequence” for the purpose of assigning sequence identifiers?
According to MPEP 2412.05(a), a “sequence” that requires a separate sequence identifier is defined by WIPO Standard ST.26, paragraph 7, as: An unbranched sequence or a linear region of a branched sequence containing ten or more specifically defined nucleotides, with adjacent nucleotides joined by a 3′ to 5′ (or 5′ to 3′) phosphodiester linkage or…
Read MoreHow should intentionally skipped sequences be represented in the “Sequence Listing XML”?
According to MPEP 2412.05(a), intentionally skipped sequences must be included in the “Sequence Listing XML” and represented as follows: Use the element SequenceData and its attribute sequenceIDNumber, providing the sequence identifier of the skipped sequence as the value. Include the elements INSDSeq_length, INSDSeq_moltype, and INSDSeq_division, but with no value provided. Do not include the element…
Read MoreWhen did the requirements for Sequence Listing XML format come into effect?
The requirements for the Sequence Listing XML format came into effect for certain patent applications filed on or after July 1, 2022. According to the editor’s note in MPEP 2412.05(a): “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as…
Read More